MARKET

BCPC

BCPC

Balchem Corp
NASDAQ
149.63
-2.40
-1.58%
After Hours: 149.63 0 0.00% 16:22 05/29 EDT
OPEN
150.61
PREV CLOSE
152.03
HIGH
151.47
LOW
149.24
VOLUME
55.93K
TURNOVER
0
52 WEEK HIGH
159.52
52 WEEK LOW
110.14
MARKET CAP
4.85B
P/E (TTM)
42.36
1D
5D
1M
3M
1Y
5Y
Balchem Corporation to Present at the Wells Fargo Industrials Conference on June 12, 2024
Balchem Corporation will present at the Wells Fargo Industrials Conference on June 12, 2024. Balchem Corporation is a global specialty ingredient manufacturer for health and nutrition markets. The company will be presenting at the conference in New York, New York. Balchem will be a sponsor of the conference.
Barchart · 22h ago
Weekly Report: what happened at BCPC last week (0520-0524)?
Weekly Report · 2d ago
Here's Why We Think Balchem (NASDAQ:BCPC) Is Well Worth Watching
Balchem's Earnings Per Share are growing over the last three years. The company has grown its earnings per share (EPS) in the same period. Balchem's CEO pay is below the average for similar sized companies. Insiders own US$35m worth of Balchem shares. The growth of EPS is a good sign for Balchem, but the company is not worth looking at. Bal chem has grown both its earnings and revenue over the years.
Simply Wall St · 3d ago
Do Options Traders Know Something About Balchem (BCPC) Stock We Don't?
NASDAQ · 05/21 12:52
Weekly Report: what happened at BCPC last week (0513-0517)?
Weekly Report · 05/20 09:29
Weekly Report: what happened at BCPC last week (0506-0510)?
Weekly Report · 05/13 09:30
Independent Director Of Balchem Sold 36% Of Their Shares
Balchem Corporation (NASDAQ:BCPC) insiders have sold shares in the last year. The biggest insider sale was by David Fischer for US$765k, at an average price of US$156. The Chairman of Balchem, Theodore Harris, made the biggest sale in the past year. Balchem insiders didn't buy any shares over the last 12 months. BalChem has a high insider ownership of the company, but the company is growing earnings. The insider sale is a warning sign for Balchem shareholders.
Simply Wall St · 05/12 12:12
Balchem: A Tale Of Two Businesses
Balchem Corporation's Q1 2024 earnings surpassed expectations. The company's Human Nutrition & Health segment is benefiting from the growth in the supplements market. Balchem's animal feed segment is encountering stiff competition in the European animal feed market. I award a Hold investment rating to Balchem Corporation.
Seeking Alpha · 05/10 08:54
More
About BCPC
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. The Company's segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. Through Specialty Products, it re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.

Webull offers Balchem Corp stock information, including NASDAQ: BCPC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BCPC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BCPC stock methods without spending real money on the virtual paper trading platform.